In vitro and In vivo Pharmacokinetic-Pharmacodynamic Relationships for the Trisubstituted Aminopurine Cyclin-Dependent Kinase Inhibitors Olomoucine, Bohemine and CYC202

MLA

Lloyd R. Kelland, et al. “In Vitro and In Vivo Pharmacokinetic-Pharmacodynamic Relationships for the Trisubstituted Aminopurine Cyclin-Dependent Kinase Inhibitors Olomoucine, Bohemine and CYC202.” Clinical Cancer Research, vol. 11, July 2005, pp. 4875–87. EBSCOhost, https://doi.org/10.1158/1078-0432.ccr-04-2264.

APA

Lloyd R. Kelland, Florence I. Raynaud, Paul Workman, Michelle D. Garrett, Suzanne A. Eccles, S. Elaine Barrie, Steven R. Whittaker, Peter Fischer, David P. Lane, L. Brunton, Steven J. McClue, Michael I. Walton, Paul Rogers, Melanie Valenti, & Simon J Clarke. (2005). In vitro and In vivo Pharmacokinetic-Pharmacodynamic Relationships for the Trisubstituted Aminopurine Cyclin-Dependent Kinase Inhibitors Olomoucine, Bohemine and CYC202. Clinical Cancer Research, 11, 4875–4887. https://doi.org/10.1158/1078-0432.ccr-04-2264

Chicago

Lloyd R. Kelland, Florence I. Raynaud, Paul Workman, Michelle D. Garrett, Suzanne A. Eccles, S. Elaine Barrie, Steven R. Whittaker, et al. 2005. “In Vitro and In Vivo Pharmacokinetic-Pharmacodynamic Relationships for the Trisubstituted Aminopurine Cyclin-Dependent Kinase Inhibitors Olomoucine, Bohemine and CYC202.” Clinical Cancer Research 11 (July): 4875–87. doi:10.1158/1078-0432.ccr-04-2264.